Skip to main content
Clinical Trials/NCT01123551
NCT01123551
Completed
Phase 3

Nebulized Morphine Versus Intravenous Morphine in the Management of Post Traumatic Pain in Emergency Department (ED)

University of Monastir1 site in 1 country200 target enrollmentJune 2010

Overview

Phase
Phase 3
Intervention
nebulized morphine
Conditions
Post Traumatic Pain
Sponsor
University of Monastir
Enrollment
200
Locations
1
Primary Endpoint
1. Resolution rate
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

In the emergency department, 60% of patients have an acute pain. Appropriate management of acute pain is a public health priority according to who recommendations. Nebulized morphine has been extensively studied in children but less well in adults.

It offers a non-invasive route for systemic drug delivery, more rapid and less invasive than intravenous (IV) method.

Registry
clinicaltrials.gov
Start Date
June 2010
End Date
July 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nouira

Professor

University of Monastir

Eligibility Criteria

Inclusion Criteria

  • Post-traumatic pain with visual analog pain scale( VAPS) ≥ 50%
  • Age between 8 and 50 years.

Exclusion Criteria

  • Glasgow coma scale (GCS)\< 14,
  • Severe injury ,
  • Hypotension : blood systolic pressure \< 90 mmhg,
  • Bradypnea \< 12 cpm or SaO2\< 90%,
  • Chronic pain treatment,
  • Aspirin or paracetamol treatment within 6 hours of emergency presentation,
  • Nasal trauma, rhinitis, nasal obstruction,
  • Incapacity to cooperate,
  • Opiate allergy,
  • Drug addiction,

Arms & Interventions

Nebulized Morphine

After randomization, patients will receive 10 mg of morphine (1ml) diluted in 4 ml normal saline and nebulized with 6 l/mn during 10 min. Nebulization will be repeated systematically 3 times every twenty minutes unless the patient pain was resolved (VAPS 30%). In addition, patients receive a bolus of IV placebo(5 ml normal saline . IV placebo (2 ml) will be repeated every 10 minutes if the objective of analgesia was not reached .

Intervention: nebulized morphine

Nebulized Morphine

After randomization, patients will receive 10 mg of morphine (1ml) diluted in 4 ml normal saline and nebulized with 6 l/mn during 10 min. Nebulization will be repeated systematically 3 times every twenty minutes unless the patient pain was resolved (VAPS 30%). In addition, patients receive a bolus of IV placebo(5 ml normal saline . IV placebo (2 ml) will be repeated every 10 minutes if the objective of analgesia was not reached .

Intervention: Intravenous morphine

Intravenous morphine

After randomization, patients will receive a bolus of 5 mg of IV morphine (5 ml. Then, 2mg of IV morphine (2ml) will be added every 10 minutes if the objective of analgesia was not reached (VAPS \>30%). In addition, normal saline (5ml)is nebulized with 6 l/mn during 10 min and will be repeated systematically every 20 minutes unless the patient's pain was not resolved (VAPS \>30%).

Intervention: Intravenous morphine

Outcomes

Primary Outcomes

1. Resolution rate

Time Frame: one hour

resolution is defined as VAPS \<30%.

Secondary Outcomes

  • Resolution time(one hour)
  • rate of side effects(one hour)

Study Sites (1)

Loading locations...

Similar Trials